Robert E Steinert, Joerg Schirra, Anne C Meyer-Gerspach, Philipp Kienle, Heiko Fischer, Felix Schulte, Burkhard Goeke, Christoph Beglinger. Am J Clin Nutr 2014
Times Cited: 34
Times Cited: 34
Times Cited
Times Co-cited
Similarity
Initial evidence that GLP-1 receptor blockade fails to suppress postprandial satiety or promote food intake in humans.
Susan J Melhorn, Vidhi Tyagi, Anne Smeraglio, Christian L Roth, Ellen A Schur. Appetite 2014
Susan J Melhorn, Vidhi Tyagi, Anne Smeraglio, Christian L Roth, Ellen A Schur. Appetite 2014
92
Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
35
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39.
C M Edwards, J F Todd, M Mahmoudi, Z Wang, R M Wang, M A Ghatei, S R Bloom. Diabetes 1999
C M Edwards, J F Todd, M Mahmoudi, Z Wang, R M Wang, M A Ghatei, S R Bloom. Diabetes 1999
32
A role for glucagon-like peptide-1 in the central regulation of feeding.
M D Turton, D O'Shea, I Gunn, S A Beak, C M Edwards, K Meeran, S J Choi, G M Taylor, M M Heath, P D Lambert,[...]. Nature 1996
M D Turton, D O'Shea, I Gunn, S A Beak, C M Edwards, K Meeran, S J Choi, G M Taylor, M M Heath, P D Lambert,[...]. Nature 1996
32
Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.
Diana L Williams, Denis G Baskin, Michael W Schwartz. Endocrinology 2009
Diana L Williams, Denis G Baskin, Michael W Schwartz. Endocrinology 2009
29
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
A Flint, A Raben, A Astrup, J J Holst. J Clin Invest 1998
A Flint, A Raben, A Astrup, J J Holst. J Clin Invest 1998
29
Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
J Schirra, K Sturm, P Leicht, R Arnold, B Göke, M Katschinski. J Clin Invest 1998
J Schirra, K Sturm, P Leicht, R Arnold, B Göke, M Katschinski. J Clin Invest 1998
29
Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia.
Adam M Deane, Nam Q Nguyen, Julie E Stevens, Robert J L Fraser, Richard H Holloway, Laura K Besanko, Carly Burgstad, Karen L Jones, Marianne J Chapman, Chris K Rayner,[...]. J Clin Endocrinol Metab 2010
Adam M Deane, Nam Q Nguyen, Julie E Stevens, Robert J L Fraser, Richard H Holloway, Laura K Besanko, Carly Burgstad, Karen L Jones, Marianne J Chapman, Chris K Rayner,[...]. J Clin Endocrinol Metab 2010
29
The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans.
Akila De Silva, Victoria Salem, Christopher J Long, Aidan Makwana, Rexford D Newbould, Eugenii A Rabiner, Mohammad A Ghatei, Stephen R Bloom, Paul M Matthews, John D Beaver,[...]. Cell Metab 2011
Akila De Silva, Victoria Salem, Christopher J Long, Aidan Makwana, Rexford D Newbould, Eugenii A Rabiner, Mohammad A Ghatei, Stephen R Bloom, Paul M Matthews, John D Beaver,[...]. Cell Metab 2011
26
Gut hormone PYY(3-36) physiologically inhibits food intake.
Rachel L Batterham, Michael A Cowley, Caroline J Small, Herbert Herzog, Mark A Cohen, Catherine L Dakin, Alison M Wren, Audrey E Brynes, Malcolm J Low, Mohammad A Ghatei,[...]. Nature 2002
Rachel L Batterham, Michael A Cowley, Caroline J Small, Herbert Herzog, Mark A Cohen, Catherine L Dakin, Alison M Wren, Audrey E Brynes, Malcolm J Low, Mohammad A Ghatei,[...]. Nature 2002
26
Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying.
Mathias Nicolaus, Julia Brödl, Rainer Linke, Hans-Juergen Woerle, Burkhard Göke, Jörg Schirra. J Clin Endocrinol Metab 2011
Mathias Nicolaus, Julia Brödl, Rainer Linke, Hans-Juergen Woerle, Burkhard Göke, Jörg Schirra. J Clin Endocrinol Metab 2011
26
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
M A Nauck, M M Heimesaat, C Orskov, J J Holst, R Ebert, W Creutzfeldt. J Clin Invest 1993
M A Nauck, M M Heimesaat, C Orskov, J J Holst, R Ebert, W Creutzfeldt. J Clin Invest 1993
26
Glucagon-like peptide-1: a potent regulator of food intake in humans.
J P Gutzwiller, B Göke, J Drewe, P Hildebrand, S Ketterer, D Handschin, R Winterhalder, D Conen, C Beglinger. Gut 1999
J P Gutzwiller, B Göke, J Drewe, P Hildebrand, S Ketterer, D Handschin, R Winterhalder, D Conen, C Beglinger. Gut 1999
23
Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.
Nils B Jørgensen, Carsten Dirksen, Kirstine N Bojsen-Møller, Siv H Jacobsen, Dorte Worm, Dorte L Hansen, Viggo B Kristiansen, Lars Naver, Sten Madsbad, Jens J Holst. Diabetes 2013
Nils B Jørgensen, Carsten Dirksen, Kirstine N Bojsen-Møller, Siv H Jacobsen, Dorte Worm, Dorte L Hansen, Viggo B Kristiansen, Lars Naver, Sten Madsbad, Jens J Holst. Diabetes 2013
23
Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.
Marzieh Salehi, Torsten P Vahl, David A D'Alessio. J Clin Endocrinol Metab 2008
Marzieh Salehi, Torsten P Vahl, David A D'Alessio. J Clin Endocrinol Metab 2008
23
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.
C Verdich, A Flint, J P Gutzwiller, E Näslund, C Beglinger, P M Hellström, S J Long, L M Morgan, J J Holst, A Astrup. J Clin Endocrinol Metab 2001
C Verdich, A Flint, J P Gutzwiller, E Näslund, C Beglinger, P M Hellström, S J Long, L M Morgan, J J Holst, A Astrup. J Clin Endocrinol Metab 2001
23
GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
Liselotte van Bloemendaal, Richard G IJzerman, Jennifer S Ten Kulve, Frederik Barkhof, Robert J Konrad, Madeleine L Drent, Dick J Veltman, Michaela Diamant. Diabetes 2014
Liselotte van Bloemendaal, Richard G IJzerman, Jennifer S Ten Kulve, Frederik Barkhof, Robert J Konrad, Madeleine L Drent, Dick J Veltman, Michaela Diamant. Diabetes 2014
23
Effect of peptide YY3-36 on food intake in humans.
Lukas Degen, Sibylle Oesch, Michel Casanova, Stefanie Graf, Silvia Ketterer, Juergen Drewe, Christoph Beglinger. Gastroenterology 2005
Lukas Degen, Sibylle Oesch, Michel Casanova, Stefanie Graf, Silvia Ketterer, Juergen Drewe, Christoph Beglinger. Gastroenterology 2005
23
The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty.
Astrid Plamboeck, Simon Veedfald, Carolyn F Deacon, Bolette Hartmann, André Wettergren, Lars B Svendsen, Søren Meisner, Claus Hovendal, Tina Vilsbøll, Filip K Knop,[...]. Am J Physiol Gastrointest Liver Physiol 2013
Astrid Plamboeck, Simon Veedfald, Carolyn F Deacon, Bolette Hartmann, André Wettergren, Lars B Svendsen, Søren Meisner, Claus Hovendal, Tina Vilsbøll, Filip K Knop,[...]. Am J Physiol Gastrointest Liver Physiol 2013
23
Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.
Robert E Steinert, Christine Feinle-Bisset, Lori Asarian, Michael Horowitz, Christoph Beglinger, Nori Geary. Physiol Rev 2017
Robert E Steinert, Christine Feinle-Bisset, Lori Asarian, Michael Horowitz, Christoph Beglinger, Nori Geary. Physiol Rev 2017
23
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
Anna Secher, Jacob Jelsing, Arian F Baquero, Jacob Hecksher-Sørensen, Michael A Cowley, Louise S Dalbøge, Gitte Hansen, Kevin L Grove, Charles Pyke, Kirsten Raun,[...]. J Clin Invest 2014
Anna Secher, Jacob Jelsing, Arian F Baquero, Jacob Hecksher-Sørensen, Michael A Cowley, Louise S Dalbøge, Gitte Hansen, Kevin L Grove, Charles Pyke, Kirsten Raun,[...]. J Clin Invest 2014
20
Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.
Elisabeth B Rüttimann, Myrtha Arnold, Jacquelien J Hillebrand, Nori Geary, Wolfgang Langhans. Endocrinology 2009
Elisabeth B Rüttimann, Myrtha Arnold, Jacquelien J Hillebrand, Nori Geary, Wolfgang Langhans. Endocrinology 2009
20
Circulating glucagon-like peptide-1 (GLP-1) inhibits eating in male rats by acting in the hindbrain and without inducing avoidance.
Mukesh Punjabi, Myrtha Arnold, Elisabeth Rüttimann, Mariana Graber, Nori Geary, Gustavo Pacheco-López, Wolfgang Langhans. Endocrinology 2014
Mukesh Punjabi, Myrtha Arnold, Elisabeth Rüttimann, Mariana Graber, Nori Geary, Gustavo Pacheco-López, Wolfgang Langhans. Endocrinology 2014
20
Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.
C Orskov, L Rabenhøj, A Wettergren, H Kofod, J J Holst. Diabetes 1994
C Orskov, L Rabenhøj, A Wettergren, H Kofod, J J Holst. Diabetes 1994
20
GLP-1 antagonism with exendin (9-39) fails to increase spontaneous meal size in rats.
Elisabeth B Rüttimann, Myrtha Arnold, Nori Geary, Wolfgang Langhans. Physiol Behav 2010
Elisabeth B Rüttimann, Myrtha Arnold, Nori Geary, Wolfgang Langhans. Physiol Behav 2010
21
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
C Verdich, S Toubro, B Buemann, J Lysgård Madsen, J Juul Holst, A Astrup. Int J Obes Relat Metab Disord 2001
C Verdich, S Toubro, B Buemann, J Lysgård Madsen, J Juul Holst, A Astrup. Int J Obes Relat Metab Disord 2001
17
Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.
Stephanie Sisley, Ruth Gutierrez-Aguilar, Michael Scott, David A D'Alessio, Darleen A Sandoval, Randy J Seeley. J Clin Invest 2014
Stephanie Sisley, Ruth Gutierrez-Aguilar, Michael Scott, David A D'Alessio, Darleen A Sandoval, Randy J Seeley. J Clin Invest 2014
17
Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans.
C Beglinger, L Degen, D Matzinger, M D'Amato, J Drewe. Am J Physiol Regul Integr Comp Physiol 2001
C Beglinger, L Degen, D Matzinger, M D'Amato, J Drewe. Am J Physiol Regul Integr Comp Physiol 2001
17
Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men.
N Geary, H R Kissileff, F X Pi-Sunyer, V Hinton. Am J Physiol 1992
N Geary, H R Kissileff, F X Pi-Sunyer, V Hinton. Am J Physiol 1992
17
Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia.
Mahesh M Umapathysivam, Michael Y Lee, Karen L Jones, Christopher E Annink, Caroline E Cousins, Laurence G Trahair, Chris K Rayner, Marianne J Chapman, Michael A Nauck, Michael Horowitz,[...]. Diabetes 2014
Mahesh M Umapathysivam, Michael Y Lee, Karen L Jones, Christopher E Annink, Caroline E Cousins, Laurence G Trahair, Chris K Rayner, Marianne J Chapman, Michael A Nauck, Michael Horowitz,[...]. Diabetes 2014
17
Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig.
C F Deacon, L Pridal, L Klarskov, M Olesen, J J Holst. Am J Physiol 1996
C F Deacon, L Pridal, L Klarskov, M Olesen, J J Holst. Am J Physiol 1996
17
Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.
Ola Lindgren, Richard D Carr, Carolyn F Deacon, Jens J Holst, Giovanni Pacini, Andrea Mari, Bo Ahrén. J Clin Endocrinol Metab 2011
Ola Lindgren, Richard D Carr, Carolyn F Deacon, Jens J Holst, Giovanni Pacini, Andrea Mari, Bo Ahrén. J Clin Endocrinol Metab 2011
17
Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses.
M A Nauck, E Homberger, E G Siegel, R C Allen, R P Eaton, R Ebert, W Creutzfeldt. J Clin Endocrinol Metab 1986
M A Nauck, E Homberger, E G Siegel, R C Allen, R P Eaton, R Ebert, W Creutzfeldt. J Clin Endocrinol Metab 1986
17
Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
J Schirra, M Nicolaus, R Roggel, M Katschinski, M Storr, H J Woerle, B Göke. Gut 2006
J Schirra, M Nicolaus, R Roggel, M Katschinski, M Storr, H J Woerle, B Göke. Gut 2006
17
Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
Tina Vilsbøll, Thure Krarup, Sten Madsbad, Jens J Holst. Regul Pept 2003
Tina Vilsbøll, Thure Krarup, Sten Madsbad, Jens J Holst. Regul Pept 2003
17
Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
Maria S Svane, Kirstine N Bojsen-Møller, Signe Nielsen, Nils B Jørgensen, Carsten Dirksen, Flemming Bendtsen, Viggo B Kristiansen, Bolette Hartmann, Jens J Holst, Sten Madsbad. Am J Physiol Endocrinol Metab 2016
Maria S Svane, Kirstine N Bojsen-Møller, Signe Nielsen, Nils B Jørgensen, Carsten Dirksen, Flemming Bendtsen, Viggo B Kristiansen, Bolette Hartmann, Jens J Holst, Sten Madsbad. Am J Physiol Endocrinol Metab 2016
17
Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
C Dirksen, N B Jørgensen, K N Bojsen-Møller, U Kielgast, S H Jacobsen, T R Clausen, D Worm, B Hartmann, J F Rehfeld, M Damgaard,[...]. Int J Obes (Lond) 2013
C Dirksen, N B Jørgensen, K N Bojsen-Møller, U Kielgast, S H Jacobsen, T R Clausen, D Worm, B Hartmann, J F Rehfeld, M Damgaard,[...]. Int J Obes (Lond) 2013
17
Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes using DPP-4 inhibition and GLP-1 receptor blockade.
Benedikt A Aulinger, Anne Bedorf, Gabriele Kutscherauer, Jocelyn de Heer, Jens J Holst, Burkhard Göke, Jörg Schirra. Diabetes 2014
Benedikt A Aulinger, Anne Bedorf, Gabriele Kutscherauer, Jocelyn de Heer, Jens J Holst, Burkhard Göke, Jörg Schirra. Diabetes 2014
17
Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
M S Svane, N B Jørgensen, K N Bojsen-Møller, C Dirksen, S Nielsen, V B Kristiansen, S Toräng, N J Wewer Albrechtsen, J F Rehfeld, B Hartmann,[...]. Int J Obes (Lond) 2016
M S Svane, N B Jørgensen, K N Bojsen-Møller, C Dirksen, S Nielsen, V B Kristiansen, S Toräng, N J Wewer Albrechtsen, J F Rehfeld, B Hartmann,[...]. Int J Obes (Lond) 2016
17
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
Carel W le Roux, Simon J B Aylwin, Rachel L Batterham, Cynthia M Borg, Frances Coyle, Vyas Prasad, Sandra Shurey, Mohammad A Ghatei, Ameet G Patel, Stephen R Bloom. Ann Surg 2006
Carel W le Roux, Simon J B Aylwin, Rachel L Batterham, Cynthia M Borg, Frances Coyle, Vyas Prasad, Sandra Shurey, Mohammad A Ghatei, Ameet G Patel, Stephen R Bloom. Ann Surg 2006
17
Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.
A Wettergren, B Schjoldager, P E Mortensen, J Myhre, J Christiansen, J J Holst. Dig Dis Sci 1993
A Wettergren, B Schjoldager, P E Mortensen, J Myhre, J Christiansen, J J Holst. Dig Dis Sci 1993
17
Stimulation of insulin secretion by gastric inhibitory polypeptide in man.
J Dupre, S A Ross, D Watson, J C Brown. J Clin Endocrinol Metab 1973
J Dupre, S A Ross, D Watson, J C Brown. J Clin Endocrinol Metab 1973
17
The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.
A Flint, A Raben, A K Ersbøll, J J Holst, A Astrup. Int J Obes Relat Metab Disord 2001
A Flint, A Raben, A K Ersbøll, J J Holst, A Astrup. Int J Obes Relat Metab Disord 2001
14
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.
J P Gutzwiller, J Drewe, B Göke, H Schmidt, B Rohrer, J Lareida, C Beglinger. Am J Physiol 1999
J P Gutzwiller, J Drewe, B Göke, H Schmidt, B Rohrer, J Lareida, C Beglinger. Am J Physiol 1999
14
Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass.
Kathrin Abegg, Marc Schiesser, Thomas A Lutz, Marco Bueter. Physiol Behav 2013
Kathrin Abegg, Marc Schiesser, Thomas A Lutz, Marco Bueter. Physiol Behav 2013
19
Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study.
Richard E Pratley, Michael A Nauck, Anthony H Barnett, Mark N Feinglos, Fernando Ovalle, Illana Harman-Boehm, June Ye, Rhona Scott, Susan Johnson, Murray Stewart,[...]. Lancet Diabetes Endocrinol 2014
Richard E Pratley, Michael A Nauck, Anthony H Barnett, Mark N Feinglos, Fernando Ovalle, Illana Harman-Boehm, June Ye, Rhona Scott, Susan Johnson, Murray Stewart,[...]. Lancet Diabetes Endocrinol 2014
14
Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men.
Ixchel M Brennan, Natalie D Luscombe-Marsh, Radhika V Seimon, Bärbel Otto, Michael Horowitz, Judith M Wishart, Christine Feinle-Bisset. Am J Physiol Gastrointest Liver Physiol 2012
Ixchel M Brennan, Natalie D Luscombe-Marsh, Radhika V Seimon, Bärbel Otto, Michael Horowitz, Judith M Wishart, Christine Feinle-Bisset. Am J Physiol Gastrointest Liver Physiol 2012
14
Critical role for peptide YY in protein-mediated satiation and body-weight regulation.
Rachel L Batterham, Helen Heffron, Saloni Kapoor, Joanna E Chivers, Keval Chandarana, Herbert Herzog, Carel W Le Roux, E Louise Thomas, Jimmy D Bell, Dominic J Withers. Cell Metab 2006
Rachel L Batterham, Helen Heffron, Saloni Kapoor, Joanna E Chivers, Keval Chandarana, Herbert Herzog, Carel W Le Roux, E Louise Thomas, Jimmy D Bell, Dominic J Withers. Cell Metab 2006
14
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.